Advancing Ethical Science: NAM-Based Drug Screening Solutions

Our Mission and Vision

At NAMina Bio, our mission is to redefine biomedical research by building a future where innovation and ethics advance together. We are dedicated to transforming drug discovery through New Approach Methodologies (NAMs) that replace outdated animal models with human-relevant, predictive systems.

Our goal is to develop an integrated platform that unites patient-derived organoids, organ-on-a-chip systems, and AI-driven predictive analytics to create a new generation of multiscale human avatars. These avatars are designed to replicate patient-specific biology with exceptional accuracy, enabling precise evaluation of drug responses and toxicity before reaching clinical trials.

NAMina Bio aims to accelerate the discovery of safer and more effective therapies, while drastically reducing the reliance on animal testing. By focusing on translational relevance and ethical responsibility, we seek to bridge the gap between preclinical studies and real patient outcomes.

Through strategic collaborations and continuous innovation, NAMina Bio is building a high-throughput screening ecosystem capable of testing both synthetic and natural compounds in human-relevant models. Our ultimate aim is to democratize precision medicine—making advanced testing platforms accessible to researchers, biotech companies, and regulators worldwide.

In doing so, NAMina Bio strives to lead a global paradigm shift: from traditional, animal-based experimentation toward ethical, data-driven, and human-centered biomedical innovation.We envision a future where personalized treatment, predictive science, and compassion coexist—reshaping how humanity discovers and develops the medicines of tomorrow.